Publikation
Generative AI
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Kanada | Publikation | July 14, 2020
In a previous publication, we announced the publication of two proposed regulations intended to broaden the scope of professional acts that Quebec pharmacists are permitted to perform.
One of these proposed regulations, the Règlement sur l’amorce et la modification d’une thérapie médicamenteuse, sur l’administration d’un médicament et sur la prescription de tests par un pharmacien (Regulation respecting the initiation and amendment of a drug therapy, the administration of a drug and the prescribing of tests by a pharmacist), proposes, among other things, to introduce “advanced practice agreements in partnership,” providing a framework in which pharmacists may work with specialized physicians or nurse practitioners. The aim is to regulate and facilitate collaborative practices already in place in interdisciplinary environments in which pharmacists work closely with other healthcare professionals.
Advanced practice agreements in partnership could be appropriate in healthcare institutions and other types of institutions and entities, including family medicine groups. These partnership agreements will be subject to certain terms and requirements, including:
For more information, please contact us, consult our blog or the Règlement sur l’amorce et la modification d’une thérapie médicamenteuse, sur l’administration d’un médicament et sur la prescription de tests par un pharmacien.
The Office des professions du Québec invites those interested to submit comments on the proposed regulations before July 27, 2020. The address to be used to send comments or to obtain additional information about the proposed regulations is published in the Gazette officielle du Québec. You can also contact us for assistance in presenting your comments.
Publikation
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publikation
Last November the Financial Conduct Authority (FCA) published Policy Statement 23/16 (PS23/16) containing final rules and guidance on sustainability disclosure requirements (SDR) and investment labels (UK SDR regime).
Publikation
We are delighted to announce that Al Hounsell, Director of Strategic Innovation & Legal Design based in our Toronto office, has been named 'Innovative Leader of the Year' at the International Legal Technology Association (ILTA) Awards.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023